Stock analysts at Maxim Group started coverage on shares of Alterity Therapeutics (NASDAQ:ATHE – Get Free Report) in a research report issued on Thursday, MarketBeat.com reports. The brokerage set a ...
Several rare immune disorders are caused by mutations in the patient's DNA. The University of Surrey and its collaborators found that targeting the mutated pathways with new drugs offers new hope for ...
The NHS has paid out tens of thousands to a man who developed an “uncontrollable” gambling problem after he was given a common Parkinson’s drug, The Independent can reveal Philip Stevens, a 66 year ...